Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
AIMS: We explored the use of highly purified murine and human pluripotent stem cell (PSC)-derived cardiomyocytes (CMs) to generate functional bioartificial cardiac tissue (BCT) and investigated the role of fibroblasts, ascorbic acid (AA), and mechanical stimuli on tissue formation, maturation, and functionality. METHODS AND RESULTS: Murine and human embryonic/induced PSC-derived CMs were genetically enriched to generate three-dimensional CM aggregates, termed cardiac bodies (CBs). Addressing the critical limitation of major CM loss after single-cell dissociation, non-dissociated CBs were used for BCT generation, which resulted in a structurally and functionally homogenous syncytium. Continuous in situ characterization of BCTs, for 21 days, revealed that three critical factors cooperatively improve BCT formation and function: both (i) addition of fibroblasts and (ii) ascorbic acid supplementation support extracellular matrix remodelling and CB fusion, and (iii) increasing static stretch supports sarcomere alignment and CM coupling. All factors together considerably enhanced the contractility of murine and human BCTs, leading to a so far unparalleled active tension of 4.4 mN/mm(2) in human BCTs using optimized conditions. Finally, advanced protocols were implemented for the generation of human PSC-derived cardiac tissue using a defined animal-free matrix composition. CONCLUSION: BCT with contractile forces comparable with native myocardium can be generated from enriched, PSC-derived CMs, based on a novel concept of tissue formation from non-dissociated cardiac cell aggregates. In combination with the successful generation of tissue using a defined animal-free matrix, this represents a major step towards clinical applicability of stem cell-based heart tissue for myocardial repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Comprehensive overview on functional and structural parameters of murine induced pluripotent stem cell-derived bioartificial cardiac tissue. ( A ) Maximum forces of murine induced pluripotent stem cell-derived bioartificial cardiac tissue from different treatment groups: C, control; A, ascorbic acid; G, G-stretch; AG, ascorbic acid and G-stretch; maximum contraction forces ( F max) measured after electrical pacing (25 V, 5 ms) showed high impact of AA and moderate influence of G-stretch on d14 and d21. ( B ) Passive forces increased over time (d14 to d21) and were significantly higher after ascorbic acid-treatment and G-stretch. ( C ) Analysis of bioartificial cardiac tissue sections immuno-stained against collagen type I showed strong influence of ascorbic acid on fibre width and alignment (in D , given as [1/angle dispersion %]), and of G-stretch on alignment only. ( E ) Numbers of DAPI-stained nuclei per mm 2 were significantly increased for ascorbic acid-treated bioartificial cardiac tissue. ( F ) Fluorescence intensities of TMRM in viable bioartificial cardiac tissue were moderately increased with ascorbic acid and significantly with G-stretch. ( G ) Both ascorbic acid and G-stretch significantly increased fluorescence intensities of titin staining of fixed cryosections. ( H ) Sarcomere length, determined in cross-striated cardiomyocytes after cardiac troponin T staining, was significantly increased in G-stretched bioartificial cardiac tissue. All columns are means + SEM, n ¼ 8-9 for (A) and (B), n ¼ 83-112 for (C), n ¼ 75-90 for (D), n ¼ 15-20 areas (0.3 mm 2 ) for (E), (F) and (G), n ¼ 77-184 for (H). * P ≤ 0.05; one-way analysis of variance for (C)-(H). See also Supplementary material online, Figure S3 and Movie S2 .](https://figures.cochat.ai/paper-figures/c229f61f5388470e93834fe147f2e41d/murine-and-human-pluripotent-stem-cell-derived-cardiac-bodies-form-contractile-figure-3.png)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“but not pressure- and volume-based metrics directly representing pump performance of the heart”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“engineered cardiac thin films, micro-tissues and strips allow the assessment of twitch force [9,12–19]”
From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
Discher, D. E., Janmey, P., & Wang, Y.-L. (2005) · Science · doi:10.1126/science.1116995 · Cited by 6,382 · cited 2×
“The molecular mechanisms supporting increased force development most probably involve a positive feedback loop of cell-mediated matrix synthesis, remodelling, and organization on the one hand, and matrix-mediated effects on cellular viability, metabolism, ultra-structure and contractility on the other hand, as propose…”
BackgroundWarren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Transient Regenerative Potential of the Neonatal Mouse Heart
Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., & Sadek, H. A. (2011) · Science · doi:10.1126/science.1200708 · Cited by 2,545
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Tiburcy, M., Hudson, J. E., Balfanz, P., Schlick, S., Meyer, T., Chang Liao, M.-L., Levent, E., Raad, F., Zeidler, S., Wingender, E., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024145 · Cited by 645
Zhang, D., Shadrin, I. Y., Lam, J., Xian, H.-Q., Snodgrass, H. R., & Bursac, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.026 · Cited by 565
Karakikes, I., Ameen, M., Termglinchan, V., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.117.305365 · Cited by 478
Ruan, J.-L., Tulloch, N. L., Razumova, M. V., Saiget, M., Muskheli, V., Pabon, L., Reinecke, H., Regnier, M., & Murry, C. E. (2016) · Circulation · doi:10.1161/circulationaha.114.014998 · Cited by 467
Cardiac Tissue Engineering: State of the Art
Hirt, M. N., Hansen, A., & Eschenhagen, T. (2014) · Circulation Research · doi:10.1161/circresaha.114.300522 · Cited by 425
Shadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N. (2017) · Nature Communications · doi:10.1038/s41467-017-01946-x · Cited by 420
Human Engineered Heart Tissue: Analysis of Contractile Force
Mannhardt, I., Breckwoldt, K., Letuffe-Brenière, D., Schaaf, S., Schulz, H., Neuber, C., Benzin, A., Werner, T., Eder, A., Schulze, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.011 · Cited by 398
“See also Figure S1. feasibility to generate human constructs and some basic characterization (Schaaf et al., 2011; Tulloch et al., 2011; Kensah et al., 2013; Nunes et al., 2013; Thavandiran et al., 2013).”
Background3D bioprinted functional and contractile cardiac tissue constructs
Wang, Z., Lee, S. J., Cheng, H.-J., Yoo, J. J., & Atala, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.02.007 · Cited by 298
Denning, C., Borgdorff, V., Crutchley, J., Firth, K. S. A., George, V., Kalra, S., Kondrashov, A., Hoang, M. D., Mosqueira, D., Patel, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.014 · Cited by 293
“As well as use in vitro, the utility of EHTs in correcting myocardial function deficit in animal models of heart failure has been tested.”
InfluentialElectrical and mechanical stimulation of cardiac cells and tissue constructs
Stoppel, W. L., Kaplan, D. L., & Black, L. D. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.009 · Cited by 289
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.033 · Cited by 272
Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
Veerman, C. C., Kosmidis, G., Mummery, C. L., Casini, S., Verkerk, A. O., & Bellin, M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0533 · Cited by 265
“In hiPSC-CMs, ascorbic acid enhanced contraction forces and sarcomeric organization and led to increased intercalated disc formation, titin expression, collagen deposition, and metabolic activity [22].”
InfluentialHuman Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model
Riegler, J., Tiburcy, M., Ebert, A., Tzatzalos, E., Raaz, U., Abilez, O. J., Shen, Q., Kooreman, N. G., Neofytou, E., Chen, V. C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306985 · Cited by 258
Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 229
Engineering Cardiac Muscle Tissue: A Maturating Field of Research
Weinberger, F., Mannhardt, I., & Eschenhagen, T. (2017) · Circulation Research · doi:10.1161/circresaha.117.310738 · Cited by 225
Ribeiro, M. C., Tertoolen, L. G., Guadix, J. A., Bellin, M., Kosmidis, G., D'Aniello, C., Monshouwer-Kloots, J., Goumans, M.-J., Wang, Y.-L., Feinberg, A. W., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.067 · Cited by 214
Kempf, H., Olmer, R., Kropp, C., Rückert, M., Jara-Avaca, M., Robles-Diaz, D., Franke, A., Elliott, D. A., Wojciechowski, D., Fischer, M., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.09.017 · Cited by 211
“WhileBCTgeneration from undissociated, contracting spheres was recently shown, this required genetic enrichment of CMs before tissue formation (Kensah et al., 2012).”
BackgroundResultInfluentialSelf-citationHuman engineered heart tissue as a model system for drug testing
Eder, A., Vollert, I., Hansen, A., & Eschenhagen, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.010 · Cited by 190
Dynamic culture yields engineered myocardium with near-adult functional output
Jackman, C. P., Carlson, A. L., & Bursac, N. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.024 · Cited by 188
“In contrast to traditional static culture of hydrogelbased engineered heart tissues [25, 50-56], this me thod relies on the application of free-floating dynamic culture conditions that lead to upregulation of mTO RC1 signaling and robust structural and functional impr ovements associated with increased cardiomyocyte d…”
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-228007 · Cited by 184
“More recently, functional cardiac tissues have been created using purified human cardiomyocyte populations (9, 19), allowing the potential benefits of nonmyocytes to be systematically examined (9).”
BackgroundMethodLi, R. A., Keung, W., Cashman, T. J., Backeris, P. C., Johnson, B. V., Bardot, E. S., Wong, A. O. T., Chan, P. K. W., Chan, C. W. Y., & Costa, K. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.024 · Cited by 175
Hydrogels for cardiac tissue engineering
Camci-Unal, G., Annabi, N., Dokmeci, M. R., Liao, R., & Khademhosseini, A. (2014) · NPG Asia Materials · doi:10.1038/am.2014.19 · Cited by 170
Preconditioning Stem Cells for In Vivo Delivery
Sart, S., Ma, T., & Li, Y. (2014) · BioResearch Open Access · doi:10.1089/biores.2014.0012 · Cited by 165
“Collagen type I ND Pluripotent stem cells Kensah et al.(78)”
BackgroundCardiac differentiation of human pluripotent stem cells in scalable suspension culture
Kempf, H., Kropp, C., Olmer, R., Martin, U., & Zweigerdt, R. (2015) · Nature Protocols · doi:10.1038/nprot.2015.089 · Cited by 160
Self-citationDirect 3D bioprinting of cardiac micro-tissues mimicking native myocardium
Liu, J., Miller, K. L., Ma, X., Dewan, S., Lawrence, N., Whang, G. J., Chung, P., McCulloch, A. D., & Chen, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120204 · Cited by 151
Dahlmann, J., Kensah, G., Kempf, H., Skvorc, D., Gawol, A., Elliott, D. A., Dräger, G., Zweigerdt, R., Martin, U., & Gruh, I. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.024 · Cited by 152
“For the mouse system, long-term aggregation (3 days) in a relatively high medium to cell ratio (20 mL/EB) as established in hanging drops [33,34] was used.”
MethodSelf-citationNatural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution
Majid, Q. A., Fricker, A. T. R., Gregory, D. A., Davidenko, N., Hernandez Cruz, O., Jabbour, R. J., Owen, T. J., Basnett, P., Lukasiewicz, B., Stevens, M., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.554597 · Cited by 131
“Custom-made bioreactors also help mature tissue constructs with the addition of vitamin C, fibroblasts, and increasing static stress (21).”
BackgroundKoch, L., Deiwick, A., Franke, A., Schwanke, K., Haverich, A., Zweigerdt, R., & Chichkov, B. (2018) · Biofabrication · doi:10.1088/1758-5090/aab981 · Cited by 130
Self-citationUse of Flow, Electrical, and Mechanical Stimulation to Promote Engineering of Striated Muscles
Rangarajan, S., Madden, L., & Bursac, N. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0966-4 · Cited by 122
Madonna, R., Laake, L. W. V., Bøtker, H. E., Davidson, S. M., Caterina, R. D., Engel, F. B., Eschenhagen, T., Fernandez-Aviles, F., Hausenloy, D. J., Hulot, J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz010 · Cited by 132
Controlled electromechanical cell stimulation on-a-chip
Pavesi, A., Adriani, G., Rasponi, M., Zervantonakis, I. K., Fiore, G. B., & Kamm, R. D. (2015) · Scientific Reports · doi:10.1038/srep11800 · Cited by 113
Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes
Zhu, R., Blazeski, A., Poon, E., Costa, K. D., Tung, L., & Boheler, K. R. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt507 · Cited by 110
“Increasing stepwise stretch of mouse iPSC-CM tissue constructs improved tissue morphology (enhanced cellular alignment and sarcomere organization), produced longer sarcomeres, and enhanced active force levels [99].”
BackgroundZhang, W., Kong, C., Tống, M. P., Chooi, W. H., Huang, N., Li, R. A., & Chan, B. P. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.058 · Cited by 120
Qasim, M., Haq, F., Kang, M. H., & Kim, J. H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s189587 · Cited by 105
“45 In some cases, only CMs failed to develop tissue construct when they were cultured alone, as endothelial cells (ECs) are important for vascularization of constructs to match nutrients demand.”
BackgroundLarge-scale production of human pluripotent stem cell derived cardiomyocytes
Kempf, H., Andree, B., & Zweigerdt, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.016 · Cited by 108
Self-citationBiomaterializing the promise of cardiac tissue engineering
Pomeroy, J. E., Helfer, A., & Bursac, N. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.009 · Cited by 107
“Collective cardiac tissue engineering efforts from multiple groups using rodent-sourced cardiomyocytes, whether primary or mouse pluripotent stem cell-derived, have led to development of 3D culture conditions that permit continued functional maturation of cells akin to postnatal cardiac development in vivo (Bian et al…”
BackgroundStriated muscle function, regeneration, and repair
Shadrin, I. Y., Khodabukus, A., & Bursac, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2285-z · Cited by 126
“Furthermore, several groups have demonstrated the crucial role that non-myocytes, primarily fibroblasts, smooth muscle cells, and endothelial cells, play in the development of functional 3D cardiac tissues [276, 286–289].”
BackgroundCell therapy, 3D culture systems and tissue engineering for cardiac regeneration
Emmert, M. Y., Hitchcock, R. W., & Hoerstrup, S. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.004 · Cited by 109
Halloin, C., Schwanke, K., Löbel, W., Franke, A., Szepes, M., Biswanath, S., Wunderlich, S., Merkert, S., Weber, N., Osten, F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.06.004 · Cited by 100
“Finally, our resulting CMs were used for bioartificial cardiac tissue (BCT) generation (Kempf et al., 2014; Kensah et al., 2013).”
MethodSelf-citationTan, Y., Richards, D., Xu, R., Stewart-Clark, S., Mani, S. K., Borg, T. K., Menick, D. R., Tian, B., & Mei, Y. (2015) · Nano Letters · doi:10.1021/nl502227a · Cited by 94
Li, Y., Asfour, H., & Bursac, N. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.04.027 · Cited by 95
Native cardiac environment and its impact on engineering cardiac tissue
Schwach, V., & Passier, R. (2019) · Biomaterials Science · doi:10.1039/c8bm01348a · Cited by 93
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
Campostrini, G., Windt, L. M., van Meer, B. J., Bellin, M., & Mummery, C. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318183 · Cited by 96
Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
Brandão, K. O., Tabel, V. A., Atsma, D. E., Mummery, C. L., & Davis, R. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030320 · Cited by 104
“Cyclic stretch and strain of hPSC-CMs, either mechanically or by electrical-field stimulation, has also generated more mature cardiomyocytes both structurally and functionally (Chan et al., 2013; Hirt et al., 2014b; Kensah et al., 2013; Nunes et al., 2013; Tulloch et al., 2011).”
BackgroundJung, J. J., Husse, B., Rimmbach, C., Krebs, S., Stieber, J., Steinhoff, G., Dendorfer, A., Franz, W.-M., & David, R. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.03.006 · Cited by 90
“Our rationale for this was based on recent reports describing the enrichment of ventricular and nodal cardiomyocytes via Myh6-based selection (Klug et al., 1996; Kensah et al., 2013; Otsuji et al., 2010), although this method was originally thought to enrich cardiomyocyte subtypes in an undirected manner.”
BackgroundMethodMicroengineered platforms for characterizing the contractile function of in vitro cardiac models
Dou, W., Malhi, M., Zhao, Q., Wang, L., Huang, Z., Law, J., Liu, N., Simmons, C. A., Maynes, J. T., & Sun, Y. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00344-0 · Cited by 92
3D Bioprinting and In Vitro Cardiovascular Tissue Modeling
Jang, J. (2017) · Bioengineering · doi:10.3390/bioengineering4030071 · Cited by 87
“This property provides relevant contractile forces by improving the degree of maturation, and over time, the engineered tissues can behave as normal heart muscles to a certain extent [89].”
BackgroundLiu, J., He, J., Liu, J., Ma, X., Chen, Q., Lawrence, N., Zhu, W., Xu, Y., & Chen, S. (2019) · Bioprinting · doi:10.1016/j.bprint.2019.e00040 · Cited by 79
“Several groups have adapted simple cantilever systems at the mm-scale producing 7 and 55 μN of force [28,29].”
Dwyer, K. D., & Coulombe, K. L. K. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.015 · Cited by 88
Miyoshi, H., & ADACHI, T. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0728 · Cited by 78
Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies
Emmert, M. Y., Wolint, P., Wickboldt, N., Gemayel, G., Weber, B., Brokopp, C. E., Boni, A., Falk, V., Bosman, A., Jaconi, M. E., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.034 · Cited by 76
“Different cell types have been used for the generation of 3D-MTs [21,27] and while recent reports indicated significant benefits for MSCs after 3D aggregationwith regards to an enhancement of their anti-inflammatory properties [20], it was also shown that the 3DMT formation using neonatal and adult cardiomyocytes as w…”
MethodMiklas, J. W., Nunes, S. S., Sofla, A., Reis, L. A., Pahnke, A., Xiao, Y., Laschinger, C., & Radisic, M. (2014) · Biofabrication · doi:10.1088/1758-5082/6/2/024113 · Cited by 69
Reconstructing the heart using iPSCs: Engineering strategies and applications
Cho, S., Lee, C., Skylar‐Scott, M. A., Heilshorn, S. C., & Wu, J. C. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.006 · Cited by 79
“To date, various in vitro tissue models have been used to assess the effects of inotropic compounds at specific concentrations [131,132], and for broader systematic screening of larger panels of drugs at varying doses [77,102,133,134].”
Backgroundvan Meer, B. J., Tertoolen, L. G. J., & Mummery, C. L. (2016) · Stem Cells · doi:10.1002/stem.2403 · Cited by 68
Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction
Rojas, S. V., Kensah, G., Rotaermel, A., Baraki, H., Kutschka, I., Zweigerdt, R., Martin, U., Haverich, A., Gruh, I., & Martens, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173222 · Cited by 74
Self-citationChen, Y., Zeng, D., Ding, L., Li, X., Liu, X., Li, W., Wei, T., Yan, S., Xie, J.-H., Li, W., et al. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0067-3 · Cited by 66
“Most experiments in cardiac tissue engineering studies have used neonatal murine CMs [12] and human/murine ESC/iPSC-derived CMs [13] combined with scaffolds that mimic the composition and/or structure features of the native ECM to some extent.”
BackgroundBan, K., Bae, S., & Yoon, Y. (2017) · Theranostics · doi:10.7150/thno.19427 · Cited by 70
“First is the beneficial role of other cell types such as endothelial cells and fibroblasts in the integration, survival, and function of CMs [30-32].”
BackgroundChristoforou, N., Liau, B., Chakraborty, S., Chellappan, M. K., Bursac, N., & Leong, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065963 · Cited by 66
“To this end, we and others have recently demonstrated that cardiomyocyte maturation and function are significantly improved in three-dimensional biosynthetic tissues [29,30].”
BackgroundKurokawa, Y. K., & George, S. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.004 · Cited by 59
Saleem, U., Mannhardt, I., Braren, I., Denning, C. N., Eschenhagen, T., & Hansen, A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.12.011 · Cited by 62
“…engineered heart tissue (hiPSC-CM EHT) (Bielawski et al., 2016; Cashman et al., 2016; Hinson et al., 2016; Jackman et al., 2016; Kensah et al., 2013; Leonard et al., 2018; Mannhardt et al., 2016;Mills et al., 2017; Nunes et al., 2013; Ronaldson-Bouchard et al., 2018; Ruan et…”
BackgroundMarchianò, S., Bertero, A., & Murry, C. E. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02165-5 · Cited by 59
Bergström, G., Christoffersson, J., Schwanke, K., Zweigerdt, R., & Mandenius, C.-F. (2015) · Lab on a Chip · doi:10.1039/c5lc00449g · Cited by 56
Self-citationCardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering
Visone, R., Gilardi, M., Marsano, A., Rasponi, M., Bersini, S., & Moretti, M. (2016) · Molecules · doi:10.3390/molecules21091128 · Cited by 56
Engineered Macroscale Cardiac Constructs Elicit Human Myocardial Tissue-like Functionality
Valls-Margarit, M., Iglesias‐García, O., Guglielmo, C. D., Sarlabous, L., Tadevosyan, K., Paoli, R., Comelles, J., Blanco-Almazán, D., Jiménez‐Delgado, S., Castillo‐Fernández, Ó., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.024 · Cited by 57
“Such microtissues are usually fabricated by using cell-laden naturalbased hydrogels cast on posts (Fennema et al., 2013; Hinson et al., 2015; Huebsch et al., 2016; Kensah et al., 2013; Ruan et al., 2016; Schaaf et al., 2011; Soong et al., 2012; Thavandiran et al., 2013; Tiburcy et al., 2017; Turnbull et al., 2014; Zha…”
BackgroundRibeiro, A. J. S., Guth, B. D., Engwall, M. J., Eldridge, S. R., Foley, C. M., Guo, L., Gintant, G. A., Koerner, J. E., Parish, S. T., Pierson, J. B., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00934 · Cited by 58
Human cardiac tissue engineering: from pluripotent stem cells to heart repair
Jackman, C. P., Shadrin, I. Y., Carlson, A. L., & Bursac, N. (2015) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2014.11.004 · Cited by 54
Feinberg, A. W., Ripplinger, C. M., van der Meer, P., Sheehy, S. P., Domian, I. J., Chien, K. R., & Parker, K. K. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.004 · Cited by 51
“The contractility of 3D tissues engineered with human ESC- and iPSC-derivedmyocytes varies widely, with peak systolic stresses in the range of 0.1–10 kPa reported in previous studies (Kensah et al., 2013; Tulloch et al., 2011; Zhang et al., 2013).”
InfluentialDou, W., Malhi, M., Cui, T., Wang, M., Wang, T., Shan, G., Law, J., Gong, Z., Plakhotnik, J., Filleter, T., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c04676 · Cited by 52
Liau, B., Jackman, C. P., Li, Y., & Bursac, N. (2017) · Scientific Reports · doi:10.1038/srep42290 · Cited by 51
Bioreactors as Engineering Support to Treat Cardiac Muscle and Vascular Disease
Massai, D., Cerino, G., Gallo, D., Pennella, F., Deriu, M. A., Rodríguez, A., Montevecchi, F. M., Bignardi, C., Audenino, A. L., & Morbiducci, U. (2013) · Journal of Healthcare Engineering · doi:10.1260/2040-2295.4.3.329 · Cited by 57
“[103] cultured highly purified murine and human pluripotent SC-derived cardiomyocytes to generate functional BCTs and to investigate the role of fibroblasts, ascorbic acid, and mechanical stimuli.”
InfluentialHeart organoids and tissue models for modeling development and disease
Miyamoto, M., Nam, L., Kannan, S., & Kwon, C. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.03.011 · Cited by 41
Seibertz, F., Sutanto, H., Dülk, R., Pronto, J. R. D., Springer, R., Rapedius, M., Liutkute, A., Ritter, M., Jung, P., Stelzer, L., et al. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-022-00973-0 · Cited by 50
“In addition to prolonged cultivation times, strategies to enhance hiPSC-CM maturity include the adoption of appropriate cardiac differentiation protocols [6], culture substrates [23] and the application of mechanical, chemical or electrical stress to hiPSC-CM embedded in 3D hydrogels or fibrin blocks to more closely r…”
Engineering the maturation of stem cell-derived cardiomyocytes
Hong, Y., Zhao, Y., Li, H., Yang, Y., Chen, M., Wang, X., Luo, M., & Wang, K. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1155052 · Cited by 48
“Recently, another team investigated the reaction of hiPSC-CM-based heart tissue to progressive stretch at different increments, observing that stretching at the highest rate (0.32 mm per day) generated an impressive MCF of 11.28 mN/mm2, a 5.1-fold increase compared to tissue stretched under fixed-length, nearly reachi…”
BackgroundInfluentialThe cardiac fibroblast: Origin, identity and role in homeostasis and disease
Furtado, M. B., Costa, M. W., & Rosenthal, N. A. (2016) · Differentiation · doi:10.1016/j.diff.2016.06.004 · Cited by 49
“In addition, fibroblasts are necessary for the formation of heart tissue derived from stem cells or induced pluripotent stem cells for bioengineering applications (Kensah et al., 2012) and Hudson J.E., UQ – personal communication).”
BackgroundMyocardial Tissue Engineering for Regenerative Applications
Fujita, B., & Zimmermann, W. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0892-4 · Cited by 44
Nakhaei‐Rad, S., Haghighi, F., Bazgir, F., Dahlmann, J., Busley, A. V., Buchholzer, M., Kleemann, K., Schänzer, A., Borchardt, A., Hahn, A., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05013-8 · Cited by 44
Self-citationSeibertz, F., Rubio, T., Springer, R., Popp, F., Ritter, M., Liutkute, A., Bartelt, L., Stelzer, L., Haghighi, F., Pietras, J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad143 · Cited by 44
Self-citationIorga, B. I., Schwanke, K., Weber, N., Wendland, M., Greten, S., Piep, B., dos Remedios, C. G., Martin, U., Zweigerdt, R., Kraft, T., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2017.01111 · Cited by 43
Self-citation3D Printed Hydrogel Multiassay Platforms for Robust Generation of Engineered Contractile Tissues
Christensen, R. K., von Halling Laier, C., Kiziltay, A., Wilson, S., & Larsen, N. B. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01274 · Cited by 38
Pluripotent Stem Cell Derived Cardiomyocytes for Cardiac Repair
Lundy, S. D., Gantz, J. A., Pagan, C. M., Filice, D., & Laflamme, M. A. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0319-0 · Cited by 45
Williams, B., Löbel, W., Finklea, F., Halloin, C., Ritzenhoff, K., Manstein, F., Mohammadi, S., Hashemi, M., Zweigerdt, R., Lipke, E., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00851 · Cited by 36
Self-citationModeling myocardial growth and hypertrophy in engineered heart muscle
Tiburcy, M., & Zimmermann, W. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.05.003 · Cited by 37
Vukadinovic-Nikolic, Z., Andrée, B., Dorfman, S. E., Pflaum, M., Horváth, T., Lux, M., Venturini, L., Bär, A., Kensah, G., Lara, A. R., et al. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0184 · Cited by 35
Self-citationProgress in Bioengineering Strategies for Heart Regenerative Medicine
Häneke, T., & Sahara, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073482 · Cited by 34
Putame, G., Gabetti, S., Carbonaro, D., Meglio, F. D., Romano, V., Sacco, A. M., Belviso, I., Serino, G., Bignardi, C., Morbiducci, U., et al. (2020) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2020.07.018 · Cited by 36
Label-free electrophysiological cytometry for stem cell-derived cardiomyocyte clusters
Myers, F. B., Zarins, C. K., Abilez, O. J., & Lee, L. P. (2012) · Lab on a Chip · doi:10.1039/c2lc40905d · Cited by 36
Halloin, C., Schwanke, K., Löbel, W., Franke, A., Szepes, M., Biswanath, S., Wunderlich, S., Merkert, S., Weber, N., Osten, F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.09.001 · Cited by 36
Self-citationKosmidis, G., Bellin, M., Ribeiro, M. C., van Meer, B. J., Oostwaard, D. W., Passier, R. C., Tertoolen, L. G. J., Mummery, C. L., & Casini, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.026 · Cited by 31
Myocardial tissue engineering for cardiac repair
Pecha, S., Eschenhagen, T., & Reichenspurner, H. C. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.12.007 · Cited by 29
Engineering stem cell therapeutics for cardiac repair
Fang, J., Li, J. J., Zhong, X., Zhou, Y., Lee, R. J., Cheng, K., & Li, S. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.06.013 · Cited by 30
Cardiac macrotissues-on-a-plate models for phenotypic drug screens
Meyer, T., Tiburcy, M., & Zimmermann, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.03.002 · Cited by 32
Hendrickson, T., Mancino, C., Whitney, L. V., Tsao, C., Rahimi, M., & Taraballi, F. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102367 · Cited by 29
Kempf, H., & Zweigerdt, R. (2017) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_30 · Cited by 29
Self-citationVascularisation for cardiac tissue engineering: the extracellular matrix
Patra, C., Boccaccini, A. R., & Engel, F. B. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0480 · Cited by 26
Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration
Cao, H., Kang, B. J., Lee, C.-A., Shung, K. K., & Hsiai, T. K. (2015) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2015.2431681 · Cited by 26
“In the last decade, specialized electrical and mechanical bioreactors [35], [36], [38]–[51] have been developed to “train” the CMs toward mature phenotypes in animal models [35], [45], [46], [52], [53].”
InfluentialGrespan, E., Martewicz, S., Serena, E., Houérou, V. L., Rühe, J., & Elvassore, N. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b03138 · Cited by 27
Szepes, M., Melchert, A., Dahlmann, J., Hegermann, J., Werlein, C., Jonigk, D. D., Haverich, A., Martin, U., Olmer, R., & Gruh, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238947 · Cited by 26
“5% cTnT cardiomyocytes following the antibiotic selection of transgenic (α-MHCp NeoR) cells [22,51] (Figure S2A–D).”
BackgroundMethodInfluentialSelf-citationBanerjee, S., Szepes, M., Dibbert, N., Rios-Camacho, J.-C., Kirschning, A., Gruh, I., & Dräger, G. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117924 · Cited by 25
Self-citationMending a broken heart by biomimetic 3D printed natural biomaterial-based cardiac patches: a review
Rosellini, E., Cascone, M. G., Guidi, L., Schubert, D. W., Roether, J. A., & Boccaccini, A. R. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1254739 · Cited by 27
Sthanam, L. K., Barai, A., Rastogi, A., Mistari, V. K., Maria, A., Kauthale, R. R., Gatne, M. M., & Sen, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.006 · Cited by 25
Metadata
- Authors
- Kensah, G., Roa Lara, A., Dahlmann, J., Zweigerdt, R., Schwanke, K., Hegermann, J., Skvorc, D., Gawol, A., Azizian, A., Wagner, S., Maier, L. S., Krause, A., Dräger, G., Ochs, M., Haverich, A., Gruh, I., & Martin, U.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- University of Göttingen (DE)
- Leibniz University Hannover (DE)
- Corresponding author
- Martin, Ulrich
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-26
- Volume
- 34
- Issue
- 15
- Pages
- 1134-1146
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2019037987
- Cited by
- 193
- References
- 59
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 10 · 2023: 17 · 2022: 7 · 2021: 9 · 2020: 14 · 2019: 16 · 2018: 14 · 2017: 25 · 2016: 20 · 2015: 20 · 2014: 18 · 2013: 14 · 2012: 1
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- green
- repo.uni-hannover.de
- Licence
- cc-by-nc-nd
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- GRO (submittedVersion)
- Leibniz Universität Hannover
- Funders
- Deutsche Forschungsgemeinschaft (EXC62/1, Exc-62, DFG EXC62, DFG EXC 62/1)
- Bundesministerium für Bildung und Forschung (01GN0958, DFG EXC 62/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- pluripotent stem cells, cardiomyocytes, fibroblasts, vitamin C, mechanical stretch, extracellular matrix remodeling, sarcomere alignment, cardiomyocyte fusion, myocardial repair, embryonic stem cells, induced pluripotent stem cells
- MeSH terms
- Animals, Ascorbic Acid, Bioprosthesis, Cell Line, Humans, Myocardial Contraction, Myocardium, Sarcomeres, Vitamins, Gene Expression, Cell Culture Techniques, Tissue Engineering, Myocytes, Cardiac, Cell Enlargement, Mice, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.